The 1 analysts offering 12-month price forecasts for Nemaura Medical Inc have a median target of 32.50, with a high estimate of 32.50 and a low estimate of 32.50. The median estimate represents a +802.25% increase from the last price of 3.60.
The current consensus among 1 polled investment analysts is to Buy stock in Nemaura Medical Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.10
Reporting Date Nov 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.